Intrust Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $962K | Sell |
3,286
-873
| -21% | -$287K | 0.08% | 170 |
|
|
2025
Q4 | $1.46M | Buy |
4,159
+781
| +23% | +$264K | 0.12% | 124 |
|
|
2025
Q3 | $1.09M | Sell |
3,378
-870
| -20% | -$271K | 0.09% | 154 |
|
|
2025
Q2 | $1.65M | Buy |
4,248
+209
| +5% | +$84.1K | 0.15% | 112 |
|
|
2025
Q1 | $1.76M | Buy |
4,039
+384
| +11% | +$154K | 0.17% | 104 |
|
|
2024
Q4 | $1.35M | Sell |
3,655
-1,183
| -24% | -$495K | 0.14% | 121 |
|
|
2024
Q3 | $2.52M | Sell |
4,838
-3
| -0.1% | -$1.6K | 0.25% | 71 |
|
|
2024
Q2 | $2.62M | Buy |
4,841
+23
| +0.5% | +$12.2K | 0.28% | 65 |
|
|
2024
Q1 | $2.5M | Sell |
4,818
-78
| -2% | -$38.8K | 0.27% | 67 |
|
|
2023
Q4 | $2.31M | Buy |
4,896
+382
| +8% | +$177K | 0.27% | 70 |
|
|
2023
Q3 | $1.97M | Sell |
4,514
-250
| -5% | -$113K | 0.25% | 77 |
|
|
2023
Q2 | $2.12M | Buy |
4,764
+25
| +0.5% | +$11.5K | 0.26% | 72 |
|
|
2023
Q1 | $2.18M | Buy |
4,739
+115
| +2% | +$54.7K | 0.28% | 63 |
|
|
2022
Q4 | $2.37M | Buy |
4,624
+47
| +1% | +$23.9K | 0.33% | 53 |
|
|
2022
Q3 | $2.08M | Buy |
4,577
+72
| +2% | +$34.5K | 0.32% | 54 |
|
|
2022
Q2 | $2.17M | Buy |
4,505
+190
| +4% | +$94K | 0.31% | 53 |
|
|
2022
Q1 | $2.12M | Buy |
4,315
+226
| +6% | +$103K | 0.27% | 70 |
|
|
2021
Q4 | $1.9M | Buy |
4,089
+133
| +3% | +$56K | 0.23% | 86 |
|
|
2021
Q3 | $1.48M | Buy |
3,956
+123
| +3% | +$46.7K | 0.2% | 99 |
|
|
2021
Q2 | $1.46M | Sell |
3,833
-60
| -2% | -$22.9K | 0.2% | 99 |
|
|
2021
Q1 | $1.4M | Sell |
3,893
-80
| -2% | -$25.7K | 0.2% | 98 |
|
|
2020
Q4 | $1.28M | Buy |
3,973
+17
| +0.4% | +$5.22K | 0.19% | 103 |
|
|
2020
Q3 | $1.06M | Sell |
3,956
-330
| -8% | -$88.8K | 0.19% | 107 |
|
|
2020
Q2 | $1.13M | Buy |
4,286
+58
| +1% | +$15.5K | 0.22% | 99 |
|
|
2020
Q1 | $960K | Buy |
4,228
+422
| +11% | +$115K | 0.27% | 92 |
|
|
2019
Q4 | $1.15M | Sell |
3,806
-57
| -1% | -$15.7K | 0.26% | 94 |
|
|
2019
Q3 | $928K | Sell |
3,863
-276
| -7% | -$75.6K | 0.23% | 104 |
|
|
2019
Q2 | $1.17M | Buy |
4,139
+145
| +4% | +$39.6K | 0.28% | 88 |
|
|
2019
Q1 | $1.15M | Buy |
3,994
+135
| +3% | +$39K | 0.29% | 76 |
|
|
2018
Q4 | $1.01M | Sell |
3,859
-50
| -1% | -$13.7K | 0.29% | 76 |
|
|
2018
Q3 | $1.07M | Sell |
3,909
-56
| -1% | -$14.5K | 0.27% | 84 |
|
|
2018
Q2 | $944K | Buy |
3,965
+84
| +2% | +$19.5K | 0.26% | 93 |
|
|
2018
Q1 | $853K | Buy |
3,881
+150
| +4% | +$35.2K | 0.25% | 104 |
|
|
2017
Q4 | $840K | Buy |
3,731
+153
| +4% | +$32.6K | 0.25% | 108 |
|
|
2017
Q3 | $680K | Buy |
3,578
+117
| +3% | +$22.3K | 0.22% | 140 |
|
|
2017
Q2 | $652K | Buy |
3,461
+309
| +10% | +$55.5K | 0.22% | 130 |
|
|
2017
Q1 | $522K | Buy |
3,152
+192
| +6% | +$30.5K | 0.18% | 157 |
|
|
2016
Q4 | $426K | Buy |
2,960
+392
| +15% | +$52.5K | 0.16% | 196 |
|
|
2016
Q3 | $322K | Buy |
2,568
+306
| +14% | +$39.5K | 0.13% | 246 |
|
|
2016
Q2 | $297K | Sell |
2,262
-212
| -9% | -$29K | 0.12% | 251 |
|
|
2016
Q1 | $344K | Sell |
2,474
-510
| -17% | -$68.2K | 0.12% | 204 |
|
|
2015
Q4 | $416K | Buy |
2,984
+178
| +6% | +$24.5K | 0.16% | 175 |
|
|
2015
Q3 | $393K | Sell |
2,806
-208
| -7% | -$31.3K | 0.15% | 178 |
|
|
2015
Q2 | $495K | Buy |
3,014
+113
| +4% | +$18.1K | 0.17% | 161 |
|
|
2015
Q1 | $448K | Buy |
2,901
+536
| +23% | +$76.3K | 0.16% | 168 |
|
|
2014
Q4 | $297K | Sell |
2,365
-181
| -7% | -$22.4K | 0.11% | 215 |
|
|
2014
Q3 | $304K | Sell |
2,546
-422
| -14% | -$48.4K | 0.12% | 200 |
|
|
2014
Q2 | $319K | Sell |
2,968
-6,209
| -68% | -$640K | 0.12% | 207 |
|
|
2014
Q1 | $913K | Sell |
9,177
-2,789
| -23% | -$252K | 0.38% | 77 |
|
|
2013
Q4 | $1.1M | Buy |
11,966
+6,367
| +114% | +$566K | 0.48% | 60 |
|
|
2013
Q3 | $468K | Sell |
5,599
-3,612
| -39% | -$310K | 0.23% | 149 |
|
|
2013
Q2 | $754K | Buy |
+9,211
| New | +$689K | 0.33% | 100 |
|
Other funds holding ELV
VCM
VPM
Intrust Bank's ELV Position: Q1 2026 in Review
Intrust Bank reduced its Elevance Health (ELV) stake by 21% in Q1 2026, selling an estimated $287K and leaving 3,286 shares worth $962K. The position accounts for 0.08% of the portfolio, ranked #170.
Intrust Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.62M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Intrust Bank held 3,286 shares of Elevance Health worth $962K as of Q1 2026.
- Intrust Bank sold 873 Elevance Health shares in Q1 2026, an estimated $287K.
- Elevance Health made up 0.08% of Intrust Bank's portfolio in Q1 2026, its #170 holding.
- Intrust Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Intrust Bank's Elevance Health position peaked at $2.62M in Q2 2024.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.